Niclosamide

CHEMBL1448 Phase 4 Onaylandı Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
327.1 g/mol
LogP
4.0
Phase
4

Originally developed as an antiparasitic, this drug is being studied for its ability to interfere with signaling pathways that help cancer cells survive.

Moleküler Ağırlık

327,1200 g/mol

LogP

4,00

TPSA

95,20 Ų

Lipinski RO5

Geçer

Terapötik Alanlar

Etki Mekanizması

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

2D Yapı

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O

InChI

InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)

Molecular Formula

C13H8Cl2N2O4

HBD / HBA

2 / 4

Döndürülebilir Bağlar

2

Ağır Atomlar

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

Originally developed as an antiparasitic, this drug is being studied for its ability to interfere with signaling pathways that help cancer cells survive.

Disrupts essential metabolic pathways or structural components of parasitic organisms, leading to paralysis, starvation, or death of the parasite.

Yes, Niclosamide is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1448. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4477. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.